127 related articles for article (PubMed ID: 23535327)
1. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.
Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2).
Zhan Y; Zhang XW; Xiong Y; Li BL; Nan FJ
Org Biomol Chem; 2016 Jan; 14(2):747-751. PubMed ID: 26584338
[TBL] [Abstract][Full Text] [Related]
5. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
7. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of A-Ring Simplified Pyripyropene A Analogues as Potent and Selective Synthetic SOAT2 Inhibitors.
Ohtawa M; Arima S; Ichida N; Terayama T; Ohno H; Yamazaki T; Ohshiro T; Sato N; Omura S; Tomoda H; Nagamitsu T
ChemMedChem; 2018 Mar; 13(5):411-421. PubMed ID: 29323466
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of alpha-pyrone meroterpenoids, novel bioactive microbial metabolites.
Sunazuka T; Omura S
Chem Rev; 2005 Dec; 105(12):4559-80. PubMed ID: 16351054
[No Abstract] [Full Text] [Related]
11. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
[TBL] [Abstract][Full Text] [Related]
12. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R.
Tomoda H; Tabata N; Yang DJ; Namatame I; Tanaka H; Omura S; Kaneko T
J Antibiot (Tokyo); 1996 Mar; 49(3):292-8. PubMed ID: 8626247
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
Ohnuma S; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
[TBL] [Abstract][Full Text] [Related]
14. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
Ohshiro T; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
[TBL] [Abstract][Full Text] [Related]
16. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of pyripyropenes fungal acyl-CoA: cholesterol acyltransferase inhibitors.
Obata R; Sunazuka T; Li Z; Tomoda H; Omura S
J Antibiot (Tokyo); 1995 Jul; 48(7):749-50. PubMed ID: 7649883
[No Abstract] [Full Text] [Related]
18. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors.
Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920
[TBL] [Abstract][Full Text] [Related]
19. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. II. Structure elucidation of pyripyropenes A, B, C and D.
Kim YK; Tomoda H; Nishida H; Sunazuka T; Obata R; Omura S
J Antibiot (Tokyo); 1994 Feb; 47(2):154-62. PubMed ID: 8150710
[TBL] [Abstract][Full Text] [Related]
20. Chemical modification and structure-activity relationships of pyripyropenes. 1. Modification at the four hydroxyl groups.
Obata R; Sunazuka T; Li Z; Tian Z; Harigaya Y; Tabata N; Tomoda H; Omura S
J Antibiot (Tokyo); 1996 Nov; 49(11):1133-48. PubMed ID: 8982343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
